iBio, Inc. (IBIO)

iBio, Inc. Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	17	10	58	329	263	14
Market Cap Growth	-45.02%	-82.21%	-82.49%	25.19%	1783.67%	33.71%
Enterprise Value	28	20	44	265	241	34
PE Ratio	-	-0.16	-1.14	-14.02	-6.87	-0.78
PS Ratio	336.32	-	30.57	138.74	160.42	6.91
PB Ratio	0.68	0.67	0.91	3.03	4.64	5.66
P/FCF Ratio	-0.80	-0.31	-1.17	-9.34	-18.12	-0.93
P/OCF Ratio	-0.76	-0.34	-1.54	-10.94	-19.69	-1.00
EV/Sales Ratio	566.84	-	23.27	111.64	146.86	17.05
EV/EBITDA Ratio	-1.18	-0.32	-0.94	-14.43	-20.50	-2.47
EV/EBIT Ratio	-1.11	-0.31	-0.87	-12.75	-17.22	-2.19
EV/FCF Ratio	-1.46	-0.60	-0.89	-7.51	-16.59	-2.30
Debt / Equity Ratio	0.72	1.14	0.41	0.30	0.58	10.10
Debt / EBITDA Ratio	-0.83	-0.27	-0.55	-1.78	-2.80	-1.78
Debt / FCF Ratio	-1.02	-0.52	-0.52	-0.93	-2.27	-1.66
Quick Ratio	0.30	0.35	1.33	14.66	10.54	1.31
Current Ratio	1.69	1.22	1.48	15.74	11.79	1.39
Asset Turnover	0.00	0	0.02	0.02	0.03	0.05
Interest Coverage	-178.55	-782.25	-	-8.46	-5.67	-8.26
Return on Equity (ROE)	-147.90%	-260.10%	-60.30%	-23.40%	-263.20%	-213.30%
Return on Assets (ROA)	-56.80%	-117.20%	-41.60%	-17.00%	-73.60%	-47.80%
Return on Capital (ROIC)	-42.48%	-89.31%	-33.27%	-22.02%	-15.64%	-57.73%
Earnings Yield	-137.74%	-634.44%	-87.49%	-7.13%	-14.56%	-127.98%
FCF Yield	-104.82%	-327.65%	-85.27%	-10.71%	-5.52%	-107.28%
Buyback Yield / Dilution	-463.43%	-40.41%	-11.45%	-211.53%	-231.79%	-78.03%
Total Shareholder Return	-463.43%	-40.41%	-11.45%	-211.53%	-231.79%	-78.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).